SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany · Delayed Price · Currency is EUR 20.20
-0.15 (-0.74%)
At close: Jul 24, 2026
ETR:1SXP Cash Flow Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Net Income | - | 146.98 | 150.35 | 151.93 | 125.85 |
Depreciation & Amortization | 85.1 | 79.44 | 64.98 | 46.65 | 55.36 |
Other Adjustments | -13.44 | -8.93 | -11.3 | -4.39 | 2.47 |
Change in Receivables | 1.58 | -31.66 | -14.43 | -26.85 | -16.27 |
Changes in Inventories | -15.98 | -29.46 | -3.41 | -15.38 | -30.64 |
Changes in Accounts Payable | -9.07 | 10.05 | 8.47 | -3.9 | 29.11 |
Changes in Accrued Expenses | 13.66 | 10.71 | 0.35 | 1.13 | 25.72 |
Changes in Unearned Revenue | 15.62 | 39.94 | 17.48 | 28.63 | 25.42 |
Changes in Other Operating Activities | -21.4 | -37.16 | 12.29 | 3.84 | -34.89 |
Operating Cash Flow | 202.46 | 179.92 | 224.77 | 181.65 | 182.12 |
Operating Cash Flow Growth | -1.68% | -19.95% | 23.74% | -0.26% | - |
Capital Expenditures | -143.42 | -144.32 | -145.08 | -175.47 | -152.01 |
Sale of Property, Plant & Equipment | 1.28 | 1.64 | 1.51 | 4.78 | 12.36 |
Purchases of Intangible Assets | -0.43 | -0.43 | -0.22 | -0.06 | -0.68 |
Purchases of Investments | -3.08 | -2.6 | -2.14 | -0.66 | -1.81 |
Proceeds from Sale of Investments | 4.35 | 2.6 | 0 | - | - |
Other Investing Activities | -24.56 | -15.92 | -109.51 | 121.7 | -136.43 |
Investing Cash Flow | -165.85 | -159.03 | -255.44 | -171.41 | -142.14 |
Long-Term Debt Issued | 2.94 | 16.68 | 61.92 | 20.89 | 14.07 |
Long-Term Debt Repaid | - | - | - | -0.02 | 0 |
Net Long-Term Debt Issued (Repaid) | 2.94 | 16.68 | 61.92 | 20.88 | 14.07 |
Common Dividends Paid | - | -24.1 | -22.59 | -18.88 | -11.46 |
Other Financing Activities | -10.37 | -13.66 | -7.41 | -135.1 | 91.43 |
Financing Cash Flow | -35.01 | -21.08 | 31.91 | -11.4 | -42.38 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.12 | -0.52 | -2.42 | -3.28 | 3.33 |
Net Cash Flow | 1.6 | -0.2 | 1.24 | -1.15 | -2.39 |
Free Cash Flow | 59.04 | 35.6 | 79.69 | 6.19 | 30.11 |
Free Cash Flow Growth | -11.30% | -55.33% | 1188.50% | -79.46% | - |
FCF Margin | 5.95% | 3.61% | 8.33% | 3.44% | 3.67% |
Free Cash Flow Per Share | 0.39 | 0.24 | 0.53 | 0.04 | 0.20 |
Levered Free Cash Flow | 70.75 | 92.33 | 166.68 | -50.09 | 57.52 |
Unlevered Free Cash Flow | 76.69 | 86.41 | 112.46 | -97.31 | 48.76 |